BAXTER HEALTHCARE has announced the approval of Artiss, a slow-setting fibrin sealant indicated as a tissue glue to seal subcutaneous tissue in plastic, reconstructive, and burn surgery, as a replacement or an adjunct to sutures or staples.
In addition, Artiss is indicated as an adjunct to haemostasis on subcutaneous tissue surfaces. The tissue adhesive was developed using Baxter’s established fibrin sealant technology platform and it is the newest product in the company’s expanding BioSurgery portfolio. Artiss provides for the delayed setting and controlled manipulation of skin grafts for approximately 60 seconds to allow for proper graft placement, as contrasted with rapid-setting fibrin sealants, which set in 5 to 10 seconds.
